Ascendis Pharma AS (ASND)
137.67
+1.19
(+0.87%)
USD |
NASDAQ |
Dec 31, 16:00
137.74
+0.07
(+0.05%)
After-Hours: 20:00
Ascendis Pharma Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Novo Nordisk AS | -3.131B |
| Evaxion Biotech AS | -- |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
| Trinity Biotech PLC | -3.101M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -5.85% |